Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: DebtBomb who wrote (10553)	8/13/2001 8:08:45 AM
From: Bocor	Respond to of 208838

CRIS having a nice pop this am on news Curis and Aegera Announce Breakthrough Adult Skin-Derived Stem Cell Research Reported in September Issue of Nature Cell Biology Opens pathways to derivation of multipotent stem cells from adult skin CAMBRIDGE, Mass. & MONTREAL--(BW HealthWire)--Aug. 13, 2001-- Curis, Inc. (NASDAQ:CRIS - news) and Aegera Therapeutics Inc. today announced publication in the journal Nature Cell Biology of a breakthrough technique in stem cell research using adult human skin. Professor Freda Miller's findings discovered at McGill University's Montreal Neurological Institute, Aegera's academic collaborator, indicate that adult skin is a source of multipotent stem cells which can be directed toward neuronal or mesodermal development, including neurons, glia, smooth muscle cells and adipocytes. Quoting from Dr. Miller's article, ``These findings indicate that adult tissues contain tissue-biased stem cells,... that may be much more `plastic' than previously appreciated... the ability to readily isolate and expand such a stem cell, from an accessible potentially autologous source such as human skin, has important therapeutic implications.''